🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.

After minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, messages show dark colored packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to potentially serious health risks”.